China Vaccine Industry Report, 2008-2009

FOR IMMEDIATE RELEASE
(Free-Press-Release.com) August 16, 2009 -- In the past decade, Chinese vaccine market tripled in scale. China has already become the world’s largest vaccine producer and now has 28 vaccine companies, ranking NO.1 around the globe. It can produce one billion person-portions annually, besides, varieties and quantity also ranks the top in the world.

Output of common vaccine reaches 500 million person-portions such as HBV vaccine, measles vaccine, etc. Fully planned immunization has been realized.

Compared to developed countries, expenses of China on vaccine and diseases treatment are relatively low; therefore, China will attach great importance to vaccine industry development and take it as the key of healthcare and bio-technology industry. The Development Strategy of China Bio-technology Industry has rendered the development of secure new types of vaccines as priority; in the meantime, Chinese government has employed preferential taxation policy to this industry. In consequence, vaccine industry will become a high-tech sector with great potential in China bio-technology field. It is forecasted that China vaccine market scale will approximate RMB8 billion in 2020, with an annual growth rate of 15%, far above world’s level 10%.

Based on authoritative statistics, this report makes in-depth analysis on China vaccine industry development, vaccine market, vaccine import & export, key vaccine producers, and also forecasts the development trend of China's vaccine industry in 2009. Vaccines involved in this report are Flu Vaccine, HBV Vaccine, Cerebrospinal Meningitis Vaccine, HIV vaccine, A/HINI vaccine as well as anima vaccines.


For details of this report please visit http://www.researchinchina.com/Htmls/Report/2009/5736.html

Contact Information
Helen Wang
Marketing Department
www.researchinchina.com
Phone: 86-10-82600893
Email: helen.wang@researchinchina.com

vaccine